Axa Has $10.80 Million Position in Agios Pharmaceuticals Inc (AGIO)

Mae Love
January 13, 2018

Swiss National Bank now owns 53,560 shares of the biopharmaceutical company's stock valued at $2,829,000 after buying an additional 6,000 shares in the last quarter. The stock ended last trade at 72.54 a share and the price is up more than 26.88% so far this year. Sell-side analyst recommendations point to a short term price target of $3 on the company shares.

Agios Pharmaceuticals, Inc. has a 52 week low of $33.50 and a 52 week high of $67.74. About 438,926 shares traded or 11.58% up from the average. Analysts are turning out to be more optimistic than before, with 9 of analysts who cover Agios Pharmaceuticals, Inc. It has underperformed by 8.18% the S&P500.

Sanders Capital Llc decreased its stake in Lennar Corp (LEN) by 13.32% based on its latest 2017Q3 regulatory filing with the SEC. Public Employees Retirement System of OH now owns 18,353 shares of the biopharmaceutical company's stock valued at $944,000 after acquiring an additional 6,338 shares in the last quarter. The total number of shares traded in the last 12 months is 1.35 million. During the same period in the previous year, the company posted ($1.63) earnings per share. (NYSE:TRV) has risen 9.71% since January 10, 2017 and is uptrending. It has outperformed by 3.21% the S&P500.

Since August 1, 2017, it had 0 insider buys, and 14 sales for $14.88 million activity. S&CO Inc. purchased a new stake in Agios Pharmaceuticals during the third quarter worth approximately $227,000. Also, insider Scott Biller sold 2,146 shares of the stock in a transaction that occurred on Wednesday, November 1st.

Dimensional Fund Advisors LP Lowers Holdings in Skyworks Solutions, Inc. (SWKS)
The company has a market cap of $18,600.00, a P/E ratio of 18.71, a price-to-earnings-growth ratio of 1.01 and a beta of 0.83. Intact Investment Management Inc. purchased a new position in Skyworks Solutions in the third quarter worth about $204,000.

$1.67 EPS Expected for United Parcel Service, Inc. (UPS)
Tnb Fincl stated it has 3,829 shares. (NYSE:CRM) has "Outperform" rating given on Thursday, November 19 by Northland Capital. The rating was maintained by Cowen & Co with "Buy" on Tuesday, December 12. (NYSE:CRM) rating on Thursday, September 1.

House votes to extend questionable NSA surveillance program for six more years
House on Thursday passed legislation reauthorizing a surveillance act after President Donald Trump first criticized the bill , and then backed it.

Its share price has risen 3.28% in three months and is up 2.70% for the last five trades. Oppenheimer Holdings, Inc. initiated coverage on Agios Pharmaceuticals in a research note on Tuesday, November 29th. For the quarter, shares are performing at 2.53%. The biopharmaceutical company reported ($1.59) EPS for the quarter, topping the Zacks' consensus estimate of ($1.78) by $0.19. Analysts predict that Agios Pharmaceuticals, Inc. will post ($5.23) EPS for the current year. The same analysts have a future one-year price target of $80.00 on the shares. Therefore 75% are positive. J.P. Morgan maintained Agios Pharmaceuticals, Inc. (NASDAQ:AGIO) on Tuesday, August 1 with "Buy" rating. Credit Suisse Ag accumulated 89,167 shares or 0.01% of the stock. The firm earned "Market Perform" rating on Monday, December 7 by Leerink Swann. The rating was maintained by Canaccord Genuity with "Buy" on Monday, June 5. (AGIO) delivered a -11.36% earnings surprise. The short interest to Agios Pharmaceuticals Incorporated's float is 17.61%. (NASDAQ:CHRW) or 406,543 shares. Cornerstone Capital Hldgs Limited Co holds 0.01% in C.H. Robinson Worldwide, Inc. (NASDAQ:AGIO) on Monday, September 18 with "Buy" rating.

Investors sentiment decreased to 1.21 in Q3 2017. (NASDAQ:AGIO). Barclays Pcl owns 0% invested in Agios Pharmaceuticals, Inc. 37 funds opened positions while 150 raised stakes. Agios Pharmaceuticals earned a media sentiment score of 0.19 on Accern's scale. (NASDAQ:AGIO). Bnp Paribas Asset has 256,086 shares for 0.14% of their portfolio. (NASDAQ:AGIO). Virginia-based Quantitative Mngmt Ltd Liability Corp has invested 0.13% in Agios Pharmaceuticals, Inc. Ameriprise Finance holds 0% or 57,504 shares. Principal Financial Grp Inc Inc holds 0% in Agios Pharmaceuticals, Inc. Artal Group Sa has 0.52% invested in Agios Pharmaceuticals, Inc. 48,111 are held by Asset One Company. Artal Gp reported 450,000 shares. Jennison Assocs Lc reported 166,065 shares or 0.01% of all its holdings. The SI to Agios Pharmaceuticals Incorporated's float is 17.61%.

In an overview of the current analyst recommendations, Buy count is 1 and Overweight is 0 while the number of analysts recommending Sell and Underweight are 0 and 0, respectively. Agios Pharmaceuticals had 41 analyst reports since July 23, 2015 according to SRatingsIntel. As per Monday, June 19, the company rating was maintained by Keefe Bruyette & Woods. The firm has "Outperform" rating by RBC Capital Markets given on Wednesday, October 21. The stock of Lennar Corporation (NYSE:LEN) has "Buy" rating given on Wednesday, October 4 by M Partners.

Ratings analysis reveals 50% of McDermott's analysts are positive. Wedbush has "Hold" rating and $60.0 target. On Tuesday, August 8 the stock rating was maintained by Cowen & Co with "Buy". Bank Of Montreal Can reported 2,031 shares stake. 187.83 million shares or 0.17% more from 187.51 million shares in 2017Q2 were reported. Verizon Communications Inc (NYSE:VZ) was raised too.

Other reports by

Discuss This Article